BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 24389438)

  • 1. Esophageal cancer recurrence patterns and implications for surveillance.
    Lou F; Sima CS; Adusumilli PS; Bains MS; Sarkaria IS; Rusch VW; Rizk NP
    J Thorac Oncol; 2013 Dec; 8(12):1558-62. PubMed ID: 24389438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local recurrence after total or subtotal esophagectomy for esophageal cancer.
    Blewett CJ; Miller JD; Ramlawi B; Young JE; BennettWF ; Urschel JD
    J Exp Clin Cancer Res; 2001 Mar; 20(1):17-9. PubMed ID: 11370823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Salvage surgery in esophageal cancer : Feasibility in patients after definitive radiochemotherapy (> 50 Gy)].
    Schmidt T; Sisic L; Sterzing F; Haag GM; Kunzmann R; Grenacher L; Weichert W; Jäger D; Büchler MW; Ott K
    Chirurg; 2015 Oct; 86(10):955-62. PubMed ID: 25715974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of patients with superficial T1 esophageal cancer who underwent endoscopic resection before esophagectomy-A propensity score-matched comparison.
    Plum PS; Hölscher AH; Pacheco Godoy K; Schmidt H; Berlth F; Chon SH; Alakus H; Bollschweiler E
    Surg Endosc; 2018 Sep; 32(9):3972-3980. PubMed ID: 29536160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma.
    Swanson SJ; Batirel HF; Bueno R; Jaklitsch MT; Lukanich JM; Allred E; Mentzer SJ; Sugarbaker DJ
    Ann Thorac Surg; 2001 Dec; 72(6):1918-24; discussion 1924-5. PubMed ID: 11789772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
    Mariette C; Taillier G; Van Seuningen I; Triboulet JP
    Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence after esophagectomy for adenocarcinoma: defining optimal follow-up intervals and testing.
    Abate E; DeMeester SR; Zehetner J; Oezcelik A; Ayazi S; Costales J; Banki F; Lipham JC; Hagen JA; DeMeester TR
    J Am Coll Surg; 2010 Apr; 210(4):428-35. PubMed ID: 20347734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas.
    Miyata H; Yamasaki M; Kurokawa Y; Takiguchi S; Nakajima K; Fujiwara Y; Konishi K; Mori M; Doki Y
    Ann Surg Oncol; 2011 Nov; 18(12):3353-61. PubMed ID: 21537861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different recurrence pattern after neoadjuvant chemoradiotherapy compared to surgery alone in esophageal cancer patients.
    Smit JK; Güler S; Beukema JC; Mul VE; Burgerhof JG; Hospers GA; Plukker JT
    Ann Surg Oncol; 2013 Nov; 20(12):4008-15. PubMed ID: 23838922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The port site recurrence after a thoracoscopic and video-assisted esophagectomy for advanced esophageal cancer.
    Yamamoto S; Kawahara K; Maekawa T; Shiraishi T; Shirakusa T
    J Thorac Oncol; 2009 Jan; 4(1):131-4. PubMed ID: 19096321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late Recurrence After Radical Resection of Esophageal Cancer.
    Hiyoshi Y; Yoshida N; Watanabe M; Kurashige J; Karashima R; Iwagami S; Baba Y; Baba H
    World J Surg; 2016 Apr; 40(4):913-20. PubMed ID: 26552914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer.
    Sharaiha RZ; Halazun KJ; Mirza F; Port JL; Lee PC; Neugut AI; Altorki NK; Abrams JA
    Ann Surg Oncol; 2011 Nov; 18(12):3362-9. PubMed ID: 21547702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence patterns and associated factors of locoregional failure following neoadjuvant chemoradiation and surgery for esophageal cancer.
    Blackham AU; H Naqvi SM; Schell MJ; Jin W; Gangi A; Almhanna K; Fontaine JP; Hoffe SE; Frakes J; Venkat P; Pimiento JM
    J Surg Oncol; 2018 Feb; 117(2):150-159. PubMed ID: 28833197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes after endoscopic mucosal resection or esophagectomy for submucosal esophageal adenocarcinoma.
    Nelson DB; Dhupar R; Katkhuda R; Correa A; Goltsov A; Maru D; Sepesi B; Antonoff MB; Mehran RJ; Rice DC; Vaporciyan AA; Davila M; Davila R; Betancourt S; Ajani J; Hofstetter WL
    J Thorac Cardiovasc Surg; 2018 Jul; 156(1):406-413.e3. PubMed ID: 29605441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative Glasgow Prognostic Score as additional independent prognostic parameter for patients with esophageal cancer after curative esophagectomy.
    Lindenmann J; Fink-Neuboeck N; Avian A; Pichler M; Habitzruther M; Maier A; Smolle-Juettner FM
    Eur J Surg Oncol; 2017 Feb; 43(2):445-453. PubMed ID: 27839896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of Microscopically Incomplete Resection Margin After Esophagectomy for Esophageal Cancer.
    Markar SR; Gronnier C; Duhamel A; Pasquer A; Théreaux J; Chalret du Rieu M; Lefevre JH; Turner K; Luc G; Mariette C;
    Ann Surg; 2016 Apr; 263(4):712-8. PubMed ID: 26135681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent.
    Parry K; Visser E; van Rossum PS; Mohammad NH; Ruurda JP; van Hillegersberg R
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1292-300. PubMed ID: 26334295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can common hepatic artery lymph node dissection be safely omitted in surgery for clinical T1N0 thoracic esophageal squamous cell carcinoma?
    Shim YM; Park JS; Lee M; Kim D; Kim K
    Dis Esophagus; 2013 Apr; 26(3):272-5. PubMed ID: 22642487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].
    Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.